©The Author(s) 2026.
World J Methodol. Mar 20, 2026; 16(1): 109733
Published online Mar 20, 2026. doi: 10.5662/wjm.v16.i1.109733
Published online Mar 20, 2026. doi: 10.5662/wjm.v16.i1.109733
Table 2 Baseline characteristics, n (%)
| Characteristic | All patients (n = 1954) | Survivors (n = 1426) | Deaths (n = 528) | P value |
| Demographics | ||||
| Age, years (mean ± SD) | 61.6 ± 15.3 | 59.4 ± 15.2 | 67.7 ± 13.7 | < 0.001 |
| Sex | 0.364 | |||
| Male | 1082 (55.4) | 778 (54.6) | 304 (57.6) | |
| Female | 872 (44.6) | 648 (45.4) | 224 (42.4) | |
| BMI, kg/m2 (mean ± SD) | 28.3 ± 7.9 | 28.5 ± 8.0 | 27.8 ± 7.7 | 0.107 |
| Comorbidities | ||||
| Charlson comorbidity index (mean ± SD) | 2.2 ± 2.2 | 2.0 ± 2.1 | 2.8 ± 2.4 | < 0.001 |
| Hypertension | 823 (42.1) | 566 (39.7) | 257 (48.7) | < 0.001 |
| Diabetes mellitus | 517 (26.5) | 362 (25.4) | 155 (29.4) | 0.079 |
| COPD | 304 (15.6) | 198 (13.9) | 106 (20.1) | 0.001 |
| Chronic kidney disease | 386 (19.8) | 247 (17.3) | 139 (26.3) | < 0.001 |
| Chronic liver disease | 215 (11.0) | 137 (9.6) | 78 (14.8) | 0.001 |
| Malignancy | 293 (15.0) | 177 (12.4) | 116 (22.0) | < 0.001 |
| Source of infection1 | 0.019 | |||
| a: Pulmonary | 809 (41.4) | 565 (39.6) | 244 (46.2) | |
| b: Urinary | 421 (21.5) | 333 (23.4) | 88 (16.7) | |
| c: Abdominal | 389 (19.9) | 288 (20.2) | 101 (19.1) | |
| d: Bloodstream | 215 (11.0) | 147 (10.3) | 68 (12.9) | |
| e: Other/unknown | 120 (6.1) | 93 (6.5) | 27 (5.1) | |
| Clinical parameters at admission | ||||
| Systolic BP, mmHg (mean ± SD) | 118.7 ± 24.5 | 121.8 ± 22.9 | 110.4 ± 26.7 | < 0.001 |
| MAP, mmHg (mean ± SD) | 78.5 ± 16.0 | 80.6 ± 14.9 | 73.0 ± 17.2 | < 0.001 |
| Heart rate, bpm (mean ± SD) | 101.3 ± 21.8 | 100.1 ± 20.9 | 104.5 ± 23.7 | < 0.001 |
| Respiratory rate, breaths/min (mean ± SD) | 22.8 ± 6.2 | 22.0 ± 5.8 | 24.9 ± 6.7 | < 0.001 |
| Temperature, °C (mean ± SD) | 37.3 ± 1.1 | 37.4 ± 1.0 | 37.0 ± 1.2 | < 0.001 |
| SpO2, % (mean ± SD) | 94.8 ± 4.7 | 95.4 ± 4.2 | 93.2 ± 5.5 | < 0.001 |
| Laboratory values | ||||
| Ferritin (mean ± SD) (ng/mL) | 1480.9 ± 2912.1 | 1196.4 ± 2423.8 | 2223.5 ± 3766.6 | < 0.001 |
| NLR (mean ± SD) | 31.6 ± 95.3 | 24.7 ± 85.6 | 50.1 ± 114.4 | < 0.001 |
| Hemoglobin, g/dL (mean ± SD) | 11.2 ± 2.3 | 11.4 ± 2.2 | 10.6 ± 2.3 | < 0.001 |
| WBC count, × 10³/μL (mean ± SD) | 15.8 ± 11.2 | 15.2 ± 10.6 | 17.3 ± 12.4 | < 0.001 |
| Platelet count, × 10³/μL (mean ± SD) | 217.3 ± 119.0 | 228.9 ± 119.8 | 186.8 ± 111.2 | < 0.001 |
| Creatinine, mg/dL (mean ± SD) | 1.7 ± 1.5 | 1.5 ± 1.3 | 2.1 ± 1.8 | < 0.001 |
| Total bilirubin, mg/dL (mean ± SD) | 1.4 ± 2.5 | 1.2 ± 2.1 | 2.0 ± 3.2 | < 0.001 |
| Lactate, mmol/L (mean ± SD) | 2.9 ± 2.4 | 2.4 ± 1.8 | 4.1 ± 3.2 | < 0.001 |
| Interventions | ||||
| Invasive ventilation | 782 (40.0) | 483 (33.9) | 299 (56.6) | < 0.001 |
| Vasopressor use | 897 (45.9) | 560 (39.3) | 337 (63.8) | < 0.001 |
| Dialysis | 326 (16.7) | 198 (13.9) | 128 (24.2) | < 0.001 |
| Outcomes | ||||
| ICU stay duration, days (mean ± SD) | 6.3 ± 7.8 | 5.9 ± 7.2 | 7.4 ± 9.1 | 0.001 |
| Hospital stay duration, days (mean ± SD) | 14.2 ± 13.4 | 15.8 ± 13.7 | 10.1 ± 11.5 | < 0.001 |
- Citation: Patel N, Patel V, Murugan Y, Patel K, Varma V, Surani S. Integrating serum ferritin and neutrophil-to-lymphocyte ratio with Sequential Organ Failure Assessment score improves mortality prediction in sepsis. World J Methodol 2026; 16(1): 109733
- URL: https://www.wjgnet.com/2222-0682/full/v16/i1/109733.htm
- DOI: https://dx.doi.org/10.5662/wjm.v16.i1.109733